Fox Run Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$361K Buy
2024
Q4
Sell
2024
Q3
$507K Buy
2024
Q2
Sell
2024
Q1
$247K Sell
2023
Q4
$392K Buy
2023
Q3
$313K Buy
2018
Q2
Sell
2018
Q1
$231K Buy
2017
Q4
Sell
2017
Q3
$461K Buy
2017
Q2
$225K Buy